Koegelenberg Coenraad F N, Theron Johan, Dheda Keertan, Bruwer J Willie, Allwood Brian W, Vorster Morné J, von Groote-Bidlingmaier Florian, Slebos Dirk-Jan, Shah Pallav L, Herth Felix J F
Pulmonology and Critical Care, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, Cape Town, South Africa.
S Afr Med J. 2015 Sep 19;105(10):810-5. doi: 10.7196/SAMJnew.8147.
Emphysema is a very common cause of morbidity and mortality in South Africa (SA). Therapeutic options in severe emphysema are limited. Endoscopic lung volume reduction (ELVR) is increasingly being used internationally for the treatment of advanced emphysema in a subset of patients with advanced disease, aiming to obtain the same functional advantages as surgical lung volume reduction while reducing risks and costs. In addition to endobronchial valves, ELVR using endobronchial coils is now available in SA. The high cost of these interventions underscores the need for careful patient selection to best identify those who may or may not benefit from ELVR-related procedures. The Assembly on Interventional Pulmonology of the South African Thoracic Society appointed a committee comprising both local and international experts to extensively review all relevant evidence and provide advice on the use of ELVR in SA based on published evidence, expert opinion and local access to the various devices.
